Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$231K Sell
2,264
-3,975
-64% -$470K 0.13% 148
2022
Q1
$840K Buy
6,239
+589
+10% +$82.8K 0.24% 114
2021
Q4
$942K Sell
5,650
-1,187
-17% -$196K 0.23% 99
2021
Q3
$993K Sell
6,837
-4,560
-40% -$744K 0.24% 90
2021
Q2
$1.84M Buy
11,397
+6,778
+147% +$912K 0.42% 43
2021
Q1
$614K Buy
4,619
+621
+16% +$86.3K 0.18% 125
2020
Q4
$566K Buy
3,998
+2,951
+282% +$391K 0.17% 131
2020
Q3
$131K Hold
1,047
0.04% 256
2020
Q2
$103K Buy
1,047
+6
+0.6% +$554 0.03% 287
2020
Q1
$86.1K Buy
1,041
+39
+4% +$3.63K 0.02% 299
2019
Q4
$103K Sell
1,002
-1,274
-56% -$120K 0.02% 312
2019
Q3
$214K Sell
2,276
-2,000
-47% -$172K 0.04% 249
2019
Q2
$359K Buy
4,276
+1,119
+35% +$94.2K 0.06% 203
2019
Q1
$266K Sell
3,157
-2,208
-41% -$182K 0.05% 196
2018
Q4
$398K Buy
5,365
+4,260
+386% +$319K 0.07% 199
2018
Q3
$94.1K Sell
1,105
-2,656
-71% -$213K 0.02% 325
2018
Q2
$300K Buy
3,761
+151
+4% +$10.6K 0.05% 213
2018
Q1
$237K Sell
3,610
-25,254
-87% -$1.67M 0.05% 230
2017
Q4
$1.81M Sell
28,864
-6,823
-19% -$392K 0.31% 52
2017
Q3
$1.85M Sell
35,687
-1,236
-3% -$69.4K 0.35% 48
2017
Q2
$2.18M Buy
36,923
+4,330
+13% +$234K 0.47% 53
2017
Q1
$1.82M Sell
32,593
-8,955
-22% -$495K 0.41% 65
2016
Q4
$2.11M Buy
41,548
+8,623
+26% +$442K 0.42% 57
2016
Q3
$1.73M Buy
32,925
+1,498
+5% +$84.6K 0.26% 71
2016
Q2
$1.73M Buy
31,427
+13,798
+78% +$786K 0.29% 58
2016
Q1
$1.08M Buy
17,629
+9,979
+130% +$603K 0.14% 84
2015
Q4
$478K Buy
7,650
+264
+4% +$17K 0.07% 120
2015
Q3
$454K Buy
7,386
+3,042
+70% +$172K 0.06% 131
2015
Q2
$235K Sell
4,344
-1,566
-26% -$80.2K 0.03% 199
2015
Q1
$296K Buy
5,910
+2,488
+73% +$119K 0.03% 176
2014
Q4
$164K Buy
+3,422
New +$160K 0.02% 238

Other funds holding NKE

Exane Derivatives's NKE Position: Q2 2022 in Review

Exane Derivatives reduced its Nike (NKE) stake by 64% in Q2 2022, selling an estimated $470K and leaving 2,264 shares worth $231K. The position accounts for 0.13% of the portfolio, ranked #148.

Exane Derivatives first reported a position in NKE in Q4 2014 and has held it in 31 quarters since. The position peaked at $2.18M in Q2 2017. 2,280 funds tracked by Wall St. Rank hold NKE as of Q2 2022.

  • Exane Derivatives held 2,264 shares of Nike worth $231K as of Q2 2022.
  • Exane Derivatives sold 3,975 Nike shares in Q2 2022, an estimated $470K.
  • Nike made up 0.13% of Exane Derivatives's portfolio in Q2 2022, its #148 holding.
  • Exane Derivatives first reported a position in Nike in Q4 2014 and has held it in 31 quarters since.
  • Exane Derivatives's Nike position peaked at $2.18M in Q2 2017.
  • 2,280 funds tracked by Wall St. Rank held Nike as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.